IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 16 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 61,530 | $23,000 | 0.00% |
| Virtu Financial LLC | 31,387 | $12,000 | 0.00% |
| BARCLAYS PLC | 50 | $0 | 0.00% |
| VANGUARD GROUP INC | 62,760 | $23,000 | 0.00% |
| UBS Group AG | 44,088 | $16,000 | 0.00% |
| NEXT Financial Group, Inc | 3,000 | $1,000 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Jacobi Capital Management LLC | 125 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 16 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $0 | 0.00% |